Haven't a medical background but the gist I think is previously inoperable pancreatic cancer patients have, since receiving the oncasil device, improved/progressed to a point where their tumour/s have been able to be removed by traditional surgical procedures.
Hopefully the ann is a refinement of this and can fire up the share price.
Ann: Presentation-Surgical Resection Outcomes and Capital Raising, page-8
Add OSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.8¢ |
Change
-0.001(11.1%) |
Mkt cap ! $35.79M | |||
| Open | High | Low | Value | Volume |
| 0.9¢ | 0.9¢ | 0.8¢ | $57.81K | 6.814M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 2730736 | 0.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.9¢ | 10051301 | 11 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| OSL (ASX) Chart |